Advanced Viral Research Corp. Announces Results Of Topical Animal Study Indicating AVR 118 Accelerates Wound Healing

YONKERS, N.Y.--(BUSINESS WIRE)--Aug. 7, 2006--Advanced Viral Research Corp. (OTC Bulletin Board: ADVR - News) a bio-pharmaceutical company, announced today that a wound healing study topically applying its pharmaceutical drug AVR 118 to pigs has shown that AVR 118 accelerates the rate at which wounds heal. Although preliminary, these studies provide the rationale for advancing AVR 118 to the human testing stage.

Back to news